Philips Announces WE-TRUST Multicenter Clinical Trial to Assess Impact of ‘Direct to Angio Suite’ Workflow on Stroke Patient Outcomes

December 2, 2019 — Amsterdam, the Netherlands – Royal Philips announced a major clinical trial to assess the impact of a ‘Direct to Angio Suite’ workflow on stroke patient outcomes. The study will assess whether with Philips’ advanced image-guided therapy platform it...

Seattle Genetics and Astellas Announce Clinical Trial Collaboration with Merck to Evaluate Enfortumab Vedotin in Combination with KEYTRUDA® (pembrolizumab) in Patients with Metastatic Urothelial Cancer

– Companies to Initiate Phase 3 Trial to Support Global Registrations – BOTHELL, Wash. & TOKYO–(BUSINESS WIRE)– Seattle Genetics, Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”),...
SEARCH FOR STUDIES